Aratana Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aratana Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 38% to $35,412,000. The net income raised on -$14,722,000 and profit margin reached -42%. Total operating expenses were $39,500,000.
Profit Margin
| 2013 | 123K | -4.28M | -3485.37% |
|---|---|---|---|
| 2014 | 767K | -38.81M | -5060.76% |
| 2015 | 678K | -84.05M | -12397.35% |
| 2016 | 38.55M | -33.57M | -87.09% |
| 2017 | 25.57M | -47.51M | -185.78% |
| 2018 | 35.41M | -14.72M | -41.57% |
PETX Income Statement (2013 – 2018)
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 35.41M | 25.57M | 38.55M | 678K | 767K | 123K |
Cost of revenue | 6.78M | 16.38M | 3.13M | 365K | 333K | 108K |
Gross profit | 28.62M | 9.18M | 35.41M | 313K | 434K | 15K |
Operating exp. | ||||||
Research and development | 6.85M | 15.12M | 30.46M | 24.96M | 19.98M | 10.92M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 39.5M | 45.84M | 57.91M | 44.86M | 37.99M | 19.49M |
Operating income | -11.88M | -44.45M | -30.81M | -89.49M | -41.60M | -19.86M |
Other income (expenses), net | -2.83M | -3.05M | -2.75M | 3.74M | 1.35M | 121K |
Income before tax | -14.72M | -47.51M | -33.57M | -85.75M | -40.25M | -19.74M |
Income tax expense | 557K | 427K | 640K | -1.69M | -1.44M | -15.45M |
Net income | -14.72M | -47.51M | -33.57M | -84.05M | -38.81M | -4.28M |
Earnings per share | ||||||
Basic EPS | -0.3 | -1.03 | -0.87 | -2.42 | -1.12 | -0.12 |
Diluted EPS | -0.3 | -1.03 | -0.87 | -2.42 | -1.12 | -0.39 |
| Data source | Data source | Data source | Data source | Data source | Data source |